(CRM) Salesforce.com - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US79466L3024

CRM Platform, Agentforce, Data Cloud, Slack, Tableau

Application Software
Market Cap in USD: 222,321m

IPO / Inception: 2004-06-23
12m vs SPY: -39.6%

EPS (Earnings per Share)

EPS CAGR: 43.45%
EPS Trend: 94.7%

Last SUE: 4.00
Qual. Beats: 2

Revenue

Rev. CAGR: 9.39%
Rev. Trend: 98.6%

Last SUE: -0.22
Qual. Beats: 0

Dividends

Dividend Yield	0.65%
Yield on Cost 5y	0.78%
Yield CAGR 5y	4.00%
Payout Consistency	100.0%
Payout Ratio	14.4%

Risk via 5d forecast
Volatility	32.7%
Value at Risk 5%th	48.9%
Relative Tail Risk	-9.16%

Reward TTM
Sharpe Ratio	-0.86
Alpha	-44.34
CAGR/Max DD	0.48

Character TTM
Hurst Exponent	0.588
Beta	0.986
Beta Downside	1.010

Drawdowns 3y
Max DD	38.37%
Mean DD	14.39%
Median DD	11.68%

Description: CRM Salesforce.com December 01, 2025

Salesforce (CRM) is a global provider of customer relationship management (CRM) software that links companies with their customers across sales, service, marketing, commerce, and analytics. Its product suite now includes Agentforce (an AI-driven agent layer), Data Cloud (a unified data engine), industry-specific AI agents, Salesforce Starter for SMBs, Slack for workplace collaboration, Tableau for end-to-end analytics, and a suite of field-service and commerce solutions. Strategic partnerships, notably with Google Workspace, embed Agentforce 360 and the emerging Salesforce Gemini AI across sales and IT workflows.

Key recent metrics: FY2024 revenue reached $27.1 billion, up ~15% YoY, with subscription and support revenue comprising roughly 90% of total-a sign of high-margin, recurring cash flow. The broader CRM software market is expanding at a ~12% CAGR, driven by accelerating digital transformation and enterprise AI adoption, which underpins Salesforce’s growth outlook. Additionally, the company’s AI-centric initiatives (Gemini, Agentforce) have begun to lift average contract values by an estimated 8% YoY, reflecting premium pricing for AI-enhanced capabilities.

For a deeper, data-driven valuation perspective, you might explore the detailed metrics on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 7.5

Net Income (7.22b TTM) > 0 and > 6% of Revenue (6% = 2.42b TTM)

FCFTA 0.14 (>2.0%) and ΔFCFTA 0.56pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -0.86% (prev 5.51%; Δ -6.37pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.14 (>3.0%) and CFO 13.50b > Net Income 7.22b (YES >=105%, WARN >=100%)

Net Debt (2.16b) to EBITDA (11.97b) ratio: 0.18 <= 3.0 (WARN <= 3.5)

Current Ratio 0.98 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (962.0m) change vs 12m ago -1.33% (target <= -2.0% for YES)

Gross Margin 77.73% (prev 76.94%; Δ 0.78pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 43.23% (prev 40.69%; Δ 2.54pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 31.79 (EBITDA TTM 11.97b / Interest Expense TTM 270.0m) >= 6 (WARN >= 3)

Altman Z'' 1.93

(A) -0.00 = (Total Current Assets 21.06b - Total Current Liabilities 21.41b) / Total Assets 95.14b

(B) 0.22 = Retained Earnings (Balance) 20.67b / Total Assets 95.14b

(D) 0.59 = Book Value of Equity 20.83b / Total Liabilities 35.12b

Total Rating: 1.93 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 82.42

1. Piotroski 7.50pt

2. FCF Yield 5.74%

3. FCF Margin 31.98%

4. Debt/Equity 0.19

5. Debt/Ebitda 0.18

6. ROIC - WACC (= 1.18)%

7. RoE 11.88%

8. Rev. Trend 98.60%

9. EPS Trend 94.69%

What is the price of CRM shares?

As of January 17, 2026, the stock is trading at USD 239.57 with a total of 10,120,836 shares traded.
Over the past week, the price has changed by -12.63%, over one month by -10.76%, over three months by -7.53% and over the past year by -28.56%.

Is CRM a buy, sell or hold?

Salesforce.com has received a consensus analysts rating of 4.22. Therefore, it is recommended to buy CRM.

Strong Buy: 28
Buy: 13
Hold: 12
Sell: 2
Strong Sell: 0

What are the forecasts/targets for the CRM price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	329.7	37.6%
Analysts Target Price	329.7	37.6%
ValueRay Target Price	248.4	3.7%

CRM Fundamental Data Overview January 17, 2026

P/E Trailing = 31.1373
P/E Forward = 18.3824
P/S = 5.5143
P/B = 3.74
P/EG = 1.1101
Revenue TTM = 40.32b USD
EBIT TTM = 8.58b USD
EBITDA TTM = 11.97b USD
Long Term Debt = 8.44b USD (from longTermDebt, last quarter)
Short Term Debt = 564.0m USD (from shortTermDebt, last quarter)
Debt = 11.14b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.16b USD (from netDebt column, last quarter)
Enterprise Value = 224.48b USD (222.32b + Debt 11.14b - CCE 8.98b)
Interest Coverage Ratio = 31.79 (Ebit TTM 8.58b / Interest Expense TTM 270.0m)
EV/FCF = 17.41x (Enterprise Value 224.48b / FCF TTM 12.89b)
FCF Yield = 5.74% (FCF TTM 12.89b / Enterprise Value 224.48b)
FCF Margin = 31.98% (FCF TTM 12.89b / Revenue TTM 40.32b)
Net Margin = 17.91% (Net Income TTM 7.22b / Revenue TTM 40.32b)
Gross Margin = 77.73% ((Revenue TTM 40.32b - Cost of Revenue TTM 8.98b) / Revenue TTM)
Gross Margin QoQ = 78.02% (prev 78.10%)
Tobins Q-Ratio = 2.36 (Enterprise Value 224.48b / Total Assets 95.14b)
Interest Expense / Debt = 0.60% (Interest Expense 67.0m / Debt 11.14b)
Taxrate = 16.96% (426.0m / 2.51b)
NOPAT = 7.13b (EBIT 8.58b * (1 - 16.96%))
Current Ratio = 0.98 (Total Current Assets 21.06b / Total Current Liabilities 21.41b)
Debt / Equity = 0.19 (Debt 11.14b / totalStockholderEquity, last quarter 60.02b)
Debt / EBITDA = 0.18 (Net Debt 2.16b / EBITDA 11.97b)
Debt / FCF = 0.17 (Net Debt 2.16b / FCF TTM 12.89b)
Total Stockholder Equity = 60.80b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.74% (Net Income 7.22b / Total Assets 95.14b)
RoE = 11.88% (Net Income TTM 7.22b / Total Stockholder Equity 60.80b)
RoCE = 12.40% (EBIT 8.58b / Capital Employed (Equity 60.80b + L.T.Debt 8.44b))
RoIC = 10.30% (NOPAT 7.13b / Invested Capital 69.23b)
WACC = 9.12% (E(222.32b)/V(233.46b) * Re(9.55%) + D(11.14b)/V(233.46b) * Rd(0.60%) * (1-Tc(0.17)))
Discount Rate = 9.55% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.97%
[DCF Debug] Terminal Value 77.71% ; FCFF base≈12.49b ; Y1≈15.40b ; Y5≈26.23b
Fair Price DCF = 383.1 (EV 361.08b - Net Debt 2.16b = Equity 358.92b / Shares 937.0m; r=9.12% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 94.69 | EPS CAGR: 43.45% | SUE: 4.0 | # QB: 2
Revenue Correlation: 98.60 | Revenue CAGR: 9.39% | SUE: -0.22 | # QB: 0
EPS next Quarter (2026-04-30): EPS=3.01 | Chg30d=-0.001 | Revisions Net=+26 | Analysts=41
EPS next Year (2027-01-31): EPS=13.11 | Chg30d=+0.062 | Revisions Net=+43 | Growth EPS=+11.4% | Growth Revenue=+10.9%

Additional Sources for CRM Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle